2-[4-[2-(2-乙酰氧基苯甲酰基)氧乙基]哌嗪-1-基]乙基2-乙酰基氧基苯甲酸酯 | 79874-85-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 2-[4-[2-(2-乙酰氧基苯甲酰基)氧乙基]哌嗪-1-基]乙基2-乙酰基氧基苯甲酸酯
• 英文名称: 1,4-BIS-[2-(ACETYLSALICYLOYLOXY)ETHYL] PIPERAZINE
• 英文别名: 1,4-bis[2-(salicyloyloxy)ethyl]piperazine；1,4-Bis(2-(acetylsalicyloyloxy)ethyl)piperazine；2-[4-[2-(2-acetyloxybenzoyl)oxyethyl]piperazin-1-yl]ethyl 2-acetyloxybenzoate
• CAS: 79874-85-4
• 化学式: C₂₆H₃₀N₂O₈
• 分子量: 498.533
• InChiKey: BJSDZTFKAMAMKC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  36
• 可旋转键数：
  14
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  112
• 氢给体数：
  0
• 氢受体数：
  10

反应信息

• 作为产物：
  描述：

  1,4-双(2-羟基乙基)哌嗪 、 邻乙酰水杨酰氯 在 碳酸氢钠 作用下， 以 二氯甲烷 为溶剂， 以2.5 g的产率得到2-[4-[2-(2-乙酰氧基苯甲酰基)氧乙基]哌嗪-1-基]乙基2-乙酰基氧基苯甲酸酯
  参考文献：
  名称：

  Process for the preparation of a pharmacologically active chemical combination

  摘要：

  制备一种药物活性化学组合物的过程，该组合物通过化学键连接相等单元构成，每个单元均具有自身的药理活性，并具有通用公式(I)：M—A—X—B—M，其中M表示具有自身药理活性的单元，X表示适合于相互连接M单元的“双齿”结构，A和B表示相等或不同的功能团，它们允许M和X之间的相互连接。

  公开号：

  US06369260B1

文献信息

• 1,4-Bis(acetylsalicyloyloxy)piperizine derivatives
  申请人：Selvi & C. S.p.A.

  公开号：US04420482A1

  公开（公告）日：1983-12-13

  The present invention concerns compounds of the general formula ##STR1## wherein X represents a direct linkage or a linear or branched oxyalkyl group containing one or more carbon atoms, as well as pharmaceutically acceptable salts of such compounds wherein X represents an oxyalkyl group, methods for their preparation by reaction of either piperazine or of its 1,4-bis-hydroxyalkyl derivatives with activated derivatives of acetylsalicylic acid such as halogenides, symmetric or mixed anhydrides, or with a haloalkylester of acetylsalicylic acid, and related pharmaceutical compositions having use as antipyretic, analgesic, anti-inflammatory and anti-histaminic agents.

  本发明涉及具有通式##STR1##的化合物，其中X代表直接连接或含有一个或多个碳原子的线型或支链的氧代烷基，以及当X代表氧代烷基时，这样的化合物的药物可接受的盐，通过反应哌嗪或其1,4-双-羟基烷基衍生物与乙酰水杨酸的活化衍生物如卤化物、对称或混合酐，或与乙酰水杨酸的卤代烷基酯，以及相关的药物组合物，用作退热剂、镇痛剂、抗炎剂和抗组胺药。
• NANOMETER-SIZED PRODRUGS OF NSAIDs
  申请人：Yu John S.

  公开号：US20110086073A1

  公开（公告）日：2011-04-14

  The present invention describes nanoprodrugs of non-steroidal anti-inflammatory drug (NSAIDs) and nanoprodrugs of α-lipoic acid-containing and NSAIDs. These nanoprodrugs have antioxidant properties and stimuli-responsiveness, which can be used to treat various disease conditions.
• NANOSPHERES COMPRISING TOCOPHEROL, AN AMPHIPHILIC SPACER AND A THERAPEUTIC OR IMAGING AGENT
  申请人：Cedars-Sinai Medical Center

  公开号：US20140105822A1

  公开（公告）日：2014-04-17

  This invention relates to a nanosphere comprising tocopherol, an amphiphilic spacer and a therapeutic agent, an imaging agent, a hydrophobic antioxidant, a hydrophobic nonsteroidal anti-inflammatory drug (NSAID) derivative, a hydrophobic antioxidant and anti-inflammatory derivative of a nonsteroidal anti-inflammatory drug (NSAID), a statin lactone derivative, an antioxidant derivative of camptothecin or camptothecin analog, or a combination thereof. Methods of synthesizing the nanospheres and their use in treating, detecting or diagnosing diseases are also provided.
• ANTIOXIDANT, NEUROPROTECTIVE AND ANTINEOPLASTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT ON AN AMPHIPHILIC SPACER OR AN AMPHIPHILIC POLYMER
  申请人：Yu John S.

  公开号：US20140140931A1

  公开（公告）日：2014-05-22

  This invention relates to antioxidant, neuroprotective and antineoplastic nanoparticles comprising a therapeutic agent on an amphiphilic spacer or an amphiphilic polymer. Methods of synthesizing the antioxidant derivatives of camptothecin and anti-oxidant derivatives of camptothecin analogs, NSAIDs and statins, spontaneous emulsification or nanoprecipitation thereof to produce antioxidant, neuroprotective and anti-neoplastic nanoparticles comprising a therapeutic agent on an amphiphilic spacer or an amphiphilic polymer and their use in treating cancerous diseases are also provided. A further aspect of this invention is the use of these neuroprotective and anti-neoplastic nanoparticles for the preparation of delivery devices of other pharmaceuticals and/or drugs.
• USE OF NANOMETER-SIZED PRODRUGS OF NSAIDs TO TREAT TRAUMATIC BRAIN INJURY
  申请人：Cedars-Sinai Medical Center

  公开号：US20160045620A1

  公开（公告）日：2016-02-18

  The present invention describes methods of delivering derivatives of non-steroidal anti-inflammatory drugs (NSAIDs) and nanospheres thereof as well as therapeutic agents to the injured brain tissue in subjects with traumatic brain injury. The invention also provides methods of treating traumatic brain injury and related conditions. The invention further provides methods of diagnosing traumatic brain injury.